Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region

BACKGROUND: The RTS,S/AS malaria candidate vaccine is being developed with the intent to be delivered, if approved, through the Expanded Programme on Immunization (EPI) of the World Health Organization. Safety, immunogenicity and efficacy of the RTS,S/AS02(D) vaccine candidate when integrated into a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Salim, Salim, Nahya, Machera, Francisca, Kamata, Richard, Juma, Omar, Shomari, Mwanajaa, Kubhoja, Sulende, Mohammed, Ali, Mwangoka, Grace, Aebi, Thomas, Mshinda, Hassan, Schellenberg, David, Carter, Terrell, Villafana, Tonya, Dubois, Marie-Claude, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Cohen, Joe, Ballou, W Ripley, Tanner, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557164/
https://www.ncbi.nlm.nih.gov/pubmed/23297680
http://dx.doi.org/10.1186/1475-2875-12-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557164/
https://www.ncbi.nlm.nih.gov/pubmed/23297680
http://dx.doi.org/10.1186/1475-2875-12-11

Ejemplares similares